Canada Pension Plan Investment Board Regeneron Pharmaceuticals, Inc. Transaction History
Canada Pension Plan Investment Board
- $132 Billion
- Q3 2025
A detailed history of Canada Pension Plan Investment Board transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 158,822 shares of REGN stock, worth $110 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
158,822
Previous 120,803
31.47%
Holding current value
$110 Million
Previous $63.4 Million
40.81%
% of portfolio
0.07%
Previous 0.06%
Shares
35 transactions
Others Institutions Holding REGN
# of Institutions
1,466Shares Held
86.5MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...